ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 168 filers reported holding ANIKA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,002 | -10.0% | 39,562 | -9.8% | 0.07% | -20.5% |
| Q1 2024 | $1,113 | -15.9% | 43,837 | -24.9% | 0.09% | -20.7% |
| Q4 2023 | $1,323 | +37.5% | 58,376 | +13.0% | 0.11% | +35.4% |
| Q3 2023 | $962 | +78.8% | 51,638 | +175.7% | 0.08% | +54.7% |
| Q1 2023 | $538 | -99.8% | 18,729 | +92.7% | 0.05% | +20.5% |
| Q4 2021 | $348,000 | -57.9% | 9,717 | -50.0% | 0.04% | -47.6% |
| Q3 2021 | $827,000 | -53.3% | 19,421 | -52.5% | 0.08% | -57.8% |
| Q2 2021 | $1,769,000 | +199.8% | 40,855 | +182.3% | 0.20% | +103.1% |
| Q1 2021 | $590,000 | +81.0% | 14,470 | +28.4% | 0.10% | +19.5% |
| Q1 2020 | $326,000 | -34.5% | 11,273 | +17.3% | 0.08% | +41.4% |
| Q4 2019 | $498,000 | -5.3% | 9,611 | +0.2% | 0.06% | -18.3% |
| Q3 2019 | $526,000 | +29.6% | 9,590 | -4.2% | 0.07% | +57.8% |
| Q2 2019 | $406,000 | -11.2% | 10,006 | -26.4% | 0.04% | -15.1% |
| Q4 2018 | $457,000 | +97.8% | 13,598 | +148.2% | 0.05% | +307.7% |
| Q3 2018 | $231,000 | +4.1% | 5,478 | +7.4% | 0.01% | +8.3% |
| Q1 2017 | $222,000 | -77.4% | 5,102 | -75.1% | 0.01% | -77.4% |
| Q3 2016 | $982,000 | +80.8% | 20,520 | +69.1% | 0.05% | +51.4% |
| Q1 2016 | $543,000 | -35.7% | 12,134 | -45.2% | 0.04% | -14.6% |
| Q4 2015 | $845,000 | +37.2% | 22,139 | +14.5% | 0.04% | +36.7% |
| Q3 2015 | $616,000 | -17.3% | 19,343 | -14.2% | 0.03% | +3.4% |
| Q2 2015 | $745,000 | +7.7% | 22,543 | +34.2% | 0.03% | +3.6% |
| Q1 2015 | $692,000 | +49.1% | 16,799 | +47.4% | 0.03% | -12.5% |
| Q4 2014 | $464,000 | -55.2% | 11,399 | -59.6% | 0.03% | -40.7% |
| Q3 2014 | $1,035,000 | -22.2% | 28,222 | -1.7% | 0.05% | -10.0% |
| Q2 2014 | $1,330,000 | +46.2% | 28,703 | +29.6% | 0.06% | -7.7% |
| Q1 2014 | $910,000 | +14.9% | 22,148 | +6.7% | 0.06% | +3.2% |
| Q4 2013 | $792,000 | +74.4% | 20,750 | +9.5% | 0.06% | +75.0% |
| Q3 2013 | $454,000 | +129.3% | 18,958 | +62.6% | 0.04% | +56.5% |
| Q2 2013 | $198,000 | – | 11,658 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
| AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
| CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
| TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
| Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
| OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
| Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
| THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
| DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |